IBDEI378 ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,51075,1,3,0)
 ;;=3^Cirrhosis of Liver,Oth
 ;;^UTILITY(U,$J,358.3,51075,1,4,0)
 ;;=4^K74.69
 ;;^UTILITY(U,$J,358.3,51075,2)
 ;;=^5008823
 ;;^UTILITY(U,$J,358.3,51076,0)
 ;;=K74.60^^193^2500^11
 ;;^UTILITY(U,$J,358.3,51076,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51076,1,3,0)
 ;;=3^Cirrhosis of Liver,Unspec
 ;;^UTILITY(U,$J,358.3,51076,1,4,0)
 ;;=4^K74.60
 ;;^UTILITY(U,$J,358.3,51076,2)
 ;;=^5008822
 ;;^UTILITY(U,$J,358.3,51077,0)
 ;;=K76.0^^193^2500^12
 ;;^UTILITY(U,$J,358.3,51077,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51077,1,3,0)
 ;;=3^Fatty Liver NEC
 ;;^UTILITY(U,$J,358.3,51077,1,4,0)
 ;;=4^K76.0
 ;;^UTILITY(U,$J,358.3,51077,2)
 ;;=^5008831
 ;;^UTILITY(U,$J,358.3,51078,0)
 ;;=K76.89^^193^2500^18
 ;;^UTILITY(U,$J,358.3,51078,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51078,1,3,0)
 ;;=3^Liver Disease NEC
 ;;^UTILITY(U,$J,358.3,51078,1,4,0)
 ;;=4^K76.89
 ;;^UTILITY(U,$J,358.3,51078,2)
 ;;=^5008835
 ;;^UTILITY(U,$J,358.3,51079,0)
 ;;=K71.6^^193^2500^32
 ;;^UTILITY(U,$J,358.3,51079,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51079,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatitis NEC
 ;;^UTILITY(U,$J,358.3,51079,1,4,0)
 ;;=4^K71.6
 ;;^UTILITY(U,$J,358.3,51079,2)
 ;;=^5008801
 ;;^UTILITY(U,$J,358.3,51080,0)
 ;;=K75.9^^193^2500^17
 ;;^UTILITY(U,$J,358.3,51080,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51080,1,3,0)
 ;;=3^Inflammatory Liver Disease,Unspec
 ;;^UTILITY(U,$J,358.3,51080,1,4,0)
 ;;=4^K75.9
 ;;^UTILITY(U,$J,358.3,51080,2)
 ;;=^5008830
 ;;^UTILITY(U,$J,358.3,51081,0)
 ;;=K71.0^^193^2500^24
 ;;^UTILITY(U,$J,358.3,51081,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51081,1,3,0)
 ;;=3^Toxic Liver Disease w/ Cholestasis
 ;;^UTILITY(U,$J,358.3,51081,1,4,0)
 ;;=4^K71.0
 ;;^UTILITY(U,$J,358.3,51081,2)
 ;;=^5008793
 ;;^UTILITY(U,$J,358.3,51082,0)
 ;;=K71.10^^193^2500^30
 ;;^UTILITY(U,$J,358.3,51082,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51082,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/o Coma
 ;;^UTILITY(U,$J,358.3,51082,1,4,0)
 ;;=4^K71.10
 ;;^UTILITY(U,$J,358.3,51082,2)
 ;;=^5008794
 ;;^UTILITY(U,$J,358.3,51083,0)
 ;;=K71.11^^193^2500^31
 ;;^UTILITY(U,$J,358.3,51083,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51083,1,3,0)
 ;;=3^Toxic Liver Disease w/ Hepatic Necrosis w/ Coma
 ;;^UTILITY(U,$J,358.3,51083,1,4,0)
 ;;=4^K71.11
 ;;^UTILITY(U,$J,358.3,51083,2)
 ;;=^5008795
 ;;^UTILITY(U,$J,358.3,51084,0)
 ;;=K71.2^^193^2500^23
 ;;^UTILITY(U,$J,358.3,51084,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51084,1,3,0)
 ;;=3^Toxic Liver Disease w/ Acute Hepatitis
 ;;^UTILITY(U,$J,358.3,51084,1,4,0)
 ;;=4^K71.2
 ;;^UTILITY(U,$J,358.3,51084,2)
 ;;=^5008796
 ;;^UTILITY(U,$J,358.3,51085,0)
 ;;=K71.3^^193^2500^28
 ;;^UTILITY(U,$J,358.3,51085,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51085,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Persistent Hepatitis
 ;;^UTILITY(U,$J,358.3,51085,1,4,0)
 ;;=4^K71.3
 ;;^UTILITY(U,$J,358.3,51085,2)
 ;;=^5008797
 ;;^UTILITY(U,$J,358.3,51086,0)
 ;;=K71.4^^193^2500^27
 ;;^UTILITY(U,$J,358.3,51086,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51086,1,3,0)
 ;;=3^Toxic Liver Disease w/ Chronic Lobular Hepatitis
 ;;^UTILITY(U,$J,358.3,51086,1,4,0)
 ;;=4^K71.4
 ;;^UTILITY(U,$J,358.3,51086,2)
 ;;=^5008798
 ;;^UTILITY(U,$J,358.3,51087,0)
 ;;=K75.81^^193^2500^19
 ;;^UTILITY(U,$J,358.3,51087,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,51087,1,3,0)
 ;;=3^Nonalcoholic Steatohepatitis (NASH)
